ANTH
Price:
$0.0001
Market Cap:
$2.62K
Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated autoimmune diseases, including immunoglobulin A nephropathy or IgA nephropathy. The company has license agreements with Amgen, Inc., and Eli Lilly and Company. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas.
Industry
Biotechnology
IPO Date
2010-03-01
Stock Exchange
OTC
Ticker
ANTH
According to Anthera Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -97.11% compared to the average of -0.35 of the last 4 quarters.
The mean historical PE Ratio of Anthera Pharmaceuticals, Inc. over the last ten years is -1.64. The current -0.01 PE Ratio has changed -38.97% with respect to the historical average. Over the past ten years (40 quarters), ANTH's PE Ratio was at its highest in in the June 2017 quarter at 0.44. The PE Ratio was at its lowest in in the June 2015 quarter at -8.68.
Average
-1.64
Median
-1.11
Minimum
-4.74
Maximum
-0.50
Discovering the peaks and valleys of Anthera Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 317.16%
Maximum Annual PE Ratio = -0.50
Minimum Annual Increase = -89.44%
Minimum Annual PE Ratio = -4.74
| Year | PE Ratio | Change |
|---|---|---|
| 2017 | -1.09 | 117.29% |
| 2016 | -0.50 | -89.44% |
| 2015 | -4.74 | 317.16% |
| 2014 | -1.14 | -32.98% |
| 2013 | -1.69 | 180.76% |
| 2012 | -0.60 | -74.96% |
| 2011 | -2.41 | -12.89% |
| 2010 | -2.77 | 218.19% |
| 2009 | -0.87 | 48.31% |
| 2008 | -0.59 | 41.96% |
The current PE Ratio of Anthera Pharmaceuticals, Inc. (ANTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.11
5-year avg
-1.83
10-year avg
-1.64
Anthera Pharmaceuticals, Inc.’s PE Ratio is less than PhaseRx, Inc. (-0.00), less than Neurobiological Technologies, Inc. (0.00), less than Synovics Pharmaceuticals, Inc. (-0.00), less than Cotinga Pharmaceuticals Inc. (-0.00), less than Sienna Biopharmaceuticals, Inc. (-0.00), less than Comera Life Sciences Holdings, Inc. (-0.00), greater than SheerVision, Inc. (-0.04), less than GlobeImmune, Inc. (-0.00), less than OncoVista Innovative Therapies, Inc. (-0.00), greater than Viveon Health Acquisition Corp. (-251.12),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $1.17K | |
| 0.00 | $2.70K | |
| -0.00 | $2.98K | |
| -0.00 | $2.20K | |
| -0.00 | $3.09K | |
| -0.00 | $3.07K | |
| -0.04 | $2.55K | |
| -0.00 | $575.00 | |
| -0.00 | $2.36K | |
| -251.12 | $66.49M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anthera Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anthera Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Anthera Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Anthera Pharmaceuticals, Inc. (ANTH)?
What is the highest PE Ratio for Anthera Pharmaceuticals, Inc. (ANTH)?
What is the 3-year average PE Ratio for Anthera Pharmaceuticals, Inc. (ANTH)?
What is the 5-year average PE Ratio for Anthera Pharmaceuticals, Inc. (ANTH)?
How does the current PE Ratio for Anthera Pharmaceuticals, Inc. (ANTH) compare to its historical average?